Implementation and outcomes of a severe acute respiratory coronavirus virus 2 (SARS-CoV-2) monoclonal antibody treatment program at an academic medical center serving a high-risk patient population

Detalles Bibliográficos
Autores principales: Borgetti, Scott A., Gross, Alan E., Kottler, Janey, Patel, Kenil, Paek, Jamie, Mena Lora, Alfredo J., Oikle, Diane, Jeffries, Delisa, Radosta, Jon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495403/
https://www.ncbi.nlm.nih.gov/pubmed/36168464
http://dx.doi.org/10.1017/ash.2021.165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9495403/
https://www.ncbi.nlm.nih.gov/pubmed/36168464
http://dx.doi.org/10.1017/ash.2021.165

Ejemplares similares